The Caronia Court Decision and Off-Label Promotion 2013 is a webinar that covers topics such as:
- The statutory and regulatory concepts of the product label
- FDA’s regulation of product labels and labeling
- FDA enforcement action against companies for off-label promotion prior to the Caronia case decision
- Product labeling as applied to both pharmaceuticals and medical devices
- The Caronia case and explanation of the Court’s decision
- The Department of Justice’s recent series of court cases and penalties for off-label promotion
- The potential impact that the decision in the Caronia Case might have on pharmaceutical and medical device companies moving forward and in the future
The Caronia Court Decision and Off-Label Promotion 2013 brings together:
- Pharmaceutical and Drug Companies, Medical Device and Biotech Companies, Start-ups, Foreign Drug Companies and Device Manufacturers, Importers
- Regulatory Affairs Professionals, Managers, Consultants, Scientists, Research Analysts, State Officials, Insurers; Investment Analysts; Venture Capitalists
- Financial analysts and investors watching the pharmaceutical, life sciences and biotech industries
- Marketing and Advertising Professionals and Experts; Consultants
